Modulators of microglial activation and polarization after intracerebral haemorrhage

Xi Lan1, Xiaoning Han1, Qian Li1

  • 1Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Building 370B, Baltimore, Maryland 21205, USA.

Insights

Intracerebral haemorrhage (ICH) lacks effective treatments. This review explores how microglia, immune cells in the brain, polarize into M1 or M2 phenotypes, influencing ICH pathology and recovery, offering therapeutic potential.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Intracerebral haemorrhage (ICH) is a severe stroke subtype with limited therapeutic options.
  • Microglia are key innate immune cells responding to brain injury, exhibiting proinflammatory (M1) and anti-inflammatory (M2) phenotypes.
  • Microglial polarization is implicated in ICH pathogenesis and resolution, involving cytokine production and phagocytosis.

Purpose of the Study:

  • To review the role of microglial activation and polarization in intracerebral haemorrhage.
  • To summarize modulators, markers, and signaling pathways of microglial phenotypes in ICH.
  • To discuss the clinical implications of targeting microglial function for ICH treatment.

Main Methods:

  • Literature review of studies on microglial response to ICH.
  • Analysis of M1/M2 microglial phenotypes, including markers and transcription factors.
  • Examination of cell-cell interactions and their impact on microglial function in ICH.

Main Results:

  • Microglial polarization into M1 (proinflammatory) and M2 (anti-inflammatory) phenotypes significantly impacts ICH.
  • M2 microglia may enhance haematoma clearance through phagocytosis of blood components and debris.
  • Interactions with neurons, astrocytes, and oligodendrocytes modulate microglial activity in the ICH environment.

Conclusions:

  • Microglial polarization is a critical factor in ICH pathology and recovery.
  • Targeting microglial phenotypes presents a promising therapeutic strategy for mitigating ICH injury.
  • Further research into microglial modulation could lead to improved clinical outcomes for ICH patients.

Related Concept Videos